J&J’s Janssen to Acquire BeneVir for $1 Billion
Janssen Biotech, part of Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson (J&J), announced on May 2, 2018 that it has entered into a defini...
Continue Reading →
